Bioelectronics Corp (BIEL)

[Simpsonly]

Here's exactly what Whelan the CEO said in the interview....

"We have what I describe as a Disruptive Pricing Strategy, we set the pricing, we're half the cost of Tylenol. We're not leaving any room for Johnson & Johnson, or ***lectronics (?), or any of the big guys to come in and figure out how to beat us on price - we have our price set, we have good margins, we're gonna (stutter)...., it's our market and we're not sharing."

My observation this time is there is a small chip on his shoulder on this, with a somewhat aggressive lift in his voice, as he found his words at the end after the stutter - why? It may simply be a competitive attitude from a CEO, which is good, but the stutter and last comment tells me there may be more to this.

Were there discussion with other companies? Did his advisors suggest he should enter into such discussions and he stubbornly refuses to do so? Are we perhaps dealing with a touch of the 'Inventors Syndrome' or inventors ego here? This is my baby and I'm gonna make it fly? Was this man offered a smaller piece of a bigger pie and ego is getting in the way? My nose is twitchng.....

Then, when he tells the story following this, the technical aspects and indications of BIEL seem to make it much more than a simple pain treatment competing with Tylenol - wound healing, healing, feet with plantar fasciitis, dental and TMJ, ankle - achilles tendons. etc., etc. He also talks about 11% of clinics in the UK using PEMF technology and then the specific words, "when we get US clearnce". He doesn't say "if" or "if we ever" or anything else - he says "when". That's pretty positive.

He talks about SUDA (sp?) the largest health group in the UK, which also has a group organized of 55 OTC distributors around the world covering 400,000 pharmacies. He says they spoke to the distributor group last year and are working on getting the products out to those pharmacies. Then he goes to different products and indications. Good interview IMO.